rfhg_68163.1

Basic information about the TSS

---

TSS ID: rfhg_68163.1 Species: human Chr: chr5		Start: 62305974 End: 62305985 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3709617,EH38E2376862)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000401507.7:177 GeneID: 3796 HGNC/MGI_ID: HGNC:6318 UniProt_ID: O00139 Nearer transcript ids and distances: ENST00000504883.2:221 ENST00000675085.1:221 ENST00000514082.6:221 ENST00000407818.8:221 ENST00000674632.1:221 ENST00000674916.1:221 ENST00000676413.1:221 ENST00000676122.1:221 ENST00000674751.1:221 ENST00000509663.2:221 NM_001243953.2:221 NM_004520.5:221 NM_001098511.3:221 NM_001243952.2:221 ENST00000381103.7:266 BC047544:266 AK297347:431 ENST00000676271.1:467 AK307880:467 EF560716:467 EF560728:473 EU832810:486 GQ129246:486 AK315866:493 view more...

Gene_name: kinesin family member 2A Gene_symbol: KIF2A Gene_synonyms: HK2 Gene_source: HGNC:6318

TATA-Box annotation

---

Distance to TSS:	-183
Nearest PromoterID:	NM_004520
Entrez ID:	3796
Nearest Unigene:	Hs.558351
Nearest Refseq:	NM_004520
Nearest Ensembl:	ENSG00000068796
Gene Name:	kinesin family member 2A
Gene Alias:	CDCBM3|HK2|KIF2
Gene Type:	protein-coding
CpG%:	0.181818
GC%:	0.416667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@KIF2A p2@KIF2A p3@KIF2A p4@KIF2A p5@KIF2A
Sample		p1@KIF2A	p2@KIF2A	p3@KIF2A	p4@KIF2A	p5@KIF2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.14	21.82	15.97	4.68	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	16.79	24.28	16.79	7.28	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	19.68	20.83	14.08	4.24	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.31	21.00	14.76	5.82	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	18.67	19.80	13.05	6.07	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.02	21.32	15.70	5.43	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	31.59	28.32	20.05	6.75	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.98	29.07	16.47	7.02	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.08	25.43	15.39	6.84	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.03	38.26	20.29	6.96	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	18.19	40.02	24.25	9.30	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.11	43.91	26.83	8.94	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.80	14.83	10.32	4.35	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.49	10.37	7.07	1.95	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	17.34	13.39	8.78	4.61	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.10	10.31	6.29	3.02	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.41	12.45	7.64	4.15	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.45	12.65	5.48	2.95	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.73	10.13	6.93	5.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	17.15	12.04	4.51	3.91	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.90	8.95	6.28	4.41	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.05	7.42	3.45	2.59	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.38	8.27	6.72	1.16	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.41	9.71	6.07	3.40	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.38	10.58	4.90	4.90	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.03	7.91	5.38	2.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.93	10.99	5.49	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.97	9.19	7.78	2.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.82	5.65	5.01	2.91	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.76	8.69	7.42	2.17	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.47	5.86	3.98	1.26	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.62	7.62	4.69	2.93	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.17	5.91	5.49	3.59	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.37	4.78	5.11	1.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.60	6.54	5.80	1.87	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.62	12.26	6.52	2.68	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.95	7.56	3.68	2.66	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.66	6.85	5.24	2.62	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.29	4.86	7.83	1.89	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.40	6.72	5.52	2.40	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.88	7.06	4.94	2.12	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.13	7.61	4.83	1.61	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.17	9.70	8.22	3.80	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.92	8.22	5.24	2.80	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.86	11.04	7.23	3.01	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.33	9.31	6.51	3.26	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.72	9.84	6.24	1.92	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.52	11.92	7.45	2.38	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	14.60	10.77	8.86	6.22	1.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.98	10.31	7.28	2.83	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	20.50	8.81	7.17	2.25	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.68	9.56	6.23	2.89	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	139.92	69.96	41.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.03	11.71	6.74	2.13	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	16.90	9.28	7.29	1.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	63.76	14.26	7.55	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	29.39	7.81	5.05	3.21	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.26	23.98	11.99	2.92	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.18	15.09	10.60	3.21	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	28.29	9.74	8.17	1.26	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	11.99	9.87	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	12.34	8.41	9.53	2.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	57.32	32.64	19.90	3.18	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	27.18	13.93	7.14	1.70	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.52	18.52	12.02	5.85	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.97	17.04	11.36	3.55	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	436.43	80.82	80.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	379.08	47.38	31.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.50	7.80	8.29	2.44	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	25.79	8.43	3.97	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	20.64	9.85	5.63	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	32.46	14.57	8.28	1.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	27.22	10.83	8.04	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.38	12.54	6.11	3.06	0.92
Adipocyte - breast, donor1	11376-118A8	14.57	4.91	2.53	0.79	0.48
Adipocyte - breast, donor2	11327-117E4	7.86	5.94	5.78	0.64	0.32
Adipocyte - omental, donor1	11473-119C6	15.14	4.96	4.83	1.91	0.38
Adipocyte - omental, donor2	11474-119C7	5.98	2.24	5.23	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	7.03	4.02	6.03	1.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	8.93	1.91	3.19	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	2.20	2.20	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	3.61	4.06	1.81	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	3.82	6.43	4.52	1.56	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	14.67	9.97	6.45	2.74	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	14.67	7.98	5.66	1.80	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	15.05	8.92	6.97	1.67	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	20.57	10.58	11.17	1.18	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	18.90	15.12	14.16	5.79	1.13
Adipocyte differentiation, day08, donor2	13023-139D8	13.23	11.94	8.07	3.23	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	8.53	12.26	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.02	6.12	6.68	2.23	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.23	7.90	5.41	4.57	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	7.79	8.04	6.78	2.26	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	9.49	7.53	2.62	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	8.53	14.61	8.53	3.35	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	4.86	5.75	4.42	1.33	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	0.36	0.72	3.23	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	2.40	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.20	4.50	2.16	1.08	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.49	4.31	3.70	1.44	0.21
Anulus Pulposus Cell, donor1	11248-116E6	25.06	2.40	2.75	1.37	0.11
Anulus Pulposus Cell, donor2	11463-119B5	8.82	2.69	4.90	2.20	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.48	2.70	2.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.37	5.21	5.21	0.87	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	2.14	8.56	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	18.23	4.18	5.08	2.09	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	7.59	3.79	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	5.28	5.28	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.97	4.87	3.25	2.27	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.71	4.85	2.91	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	15.44	6.53	4.16	2.38	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.20	6.03	3.39	2.64	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	2.90	2.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	2.51	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	20.26	4.94	3.29	1.81	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	5.46	4.09	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	10.71	3.17	2.26	1.06	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.64	3.21	4.82	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.60	2.83	3.40	1.70	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.36	2.94	1.87	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	6.83	4.88	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.43	4.31	4.15	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	1.20	1.20	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	7.08	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	11.84	4.80	3.09	1.20	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.53	6.31	1.94	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.11	6.45	5.69	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	7.27	3.63	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.11	3.99	5.13	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.61	4.70	3.63	0.86	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.90	4.90	4.39	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	12.20	4.69	1.88	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.32	4.18	2.89	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	2.14	2.14	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.11	4.09	3.51	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.37	3.61	1.20	1.51	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	4.75	4.75	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	18.82	4.58	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.65	3.31	2.29	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	4.45	3.81	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.95	6.47	4.32	1.29	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.03	3.81	3.81	0.85	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.60	3.48	1.16	1.74	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	6.61	4.72	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	11.19	5.09	3.39	1.02	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	6.95	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	10.56	6.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.01	3.43	3.22	1.72	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.63	4.21	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	3.64	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.71	4.14	2.99	1.15	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	2.55	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.47	6.10	3.56	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.28	3.51	2.68	1.86	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.49	4.59	1.22	0.92	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	22.47	5.26	2.39	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.53	4.21	3.77	2.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	1.53	4.58	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.85	6.65	3.88	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.12	5.03	2.12	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.54	5.45	3.63	1.45	0.36
Astrocyte - cerebellum, donor1	11500-119F6	9.09	3.81	5.53	2.33	0.74
Astrocyte - cerebellum, donor2	11580-120F5	2.57	3.77	3.94	1.88	0.17
Astrocyte - cerebellum, donor3	11661-122F5	2.94	4.19	3.15	0.84	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	44.62	12.90	8.02	10.81	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	24.43	19.09	11.00	6.79	1.78
Astrocyte - cerebral cortex, donor3	11392-118C6	28.94	18.79	10.89	9.70	1.79
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	84.18	41.52	37.85	19.15	2.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	88.82	46.23	36.96	17.41	2.51
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	99.91	42.33	43.58	15.25	2.96
Basophils, donor1	12241-129G9	7.32	7.06	10.72	0.26	0.26
Basophils, donor2	12242-129H1	59.17	15.15	28.86	2.53	0.36
Basophils, donor3	12243-129H2	8.38	5.44	8.67	1.47	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	1.29	2.37	2.80	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.46	2.29	1.83	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	10.04	1.26	3.77	2.51	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	2.50	5.82	2.70	0.83	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	6.68	1.61	3.45	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	19.25	5.94	4.32	1.44	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	82.44	23.08	25.97	11.44	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	74.76	27.72	25.39	11.41	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	43.17	16.31	15.35	9.91	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	10.34	31.03	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	18.03	5.64	9.58	3.38	0.00
CD14+ Monocytes, donor2	11305-117B9	12.06	13.55	13.73	1.48	0.19
CD14+ Monocytes, donor3	11381-118B4	12.07	9.88	14.05	1.32	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	24.91	5.38	6.51	2.55	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	33.74	12.13	9.86	3.41	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.96	8.88	9.53	3.94	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	10.55	5.78	7.37	0.87	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	11.16	6.03	11.77	1.51	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	8.53	7.58	9.48	0.95	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.02	2.01	2.85	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.59	5.80	4.69	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.21	3.72	4.21	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.05	8.03	13.90	1.37	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.83	15.13	16.91	1.07	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.62	10.66	20.89	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.17	2.34	2.58	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	2.64	3.17	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	1.11	4.44	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.42	2.23	4.16	0.59	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.99	1.80	2.39	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.25	1.87	2.50	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.06	1.83	4.12	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.39	2.04	4.75	0.68	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.62	2.62	1.75	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	22.86	20.17	34.43	3.77	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.86	24.77	28.79	1.92	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	22.30	25.25	34.51	2.10	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	0.92	1.65	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.47	1.41	4.23	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.32	3.07	3.95	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.75	6.63	9.42	1.22	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.06	11.89	15.98	1.12	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.93	10.56	13.36	1.51	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.55	4.50	4.50	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.78	2.55	2.55	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.78	1.16	1.86	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	14.82	5.01	5.23	0.65	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	12.70	6.93	9.47	1.15	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	12.78	4.98	5.63	0.87	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	19.15	9.97	9.81	1.25	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	19.56	9.08	7.68	1.40	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	32.11	13.16	15.38	4.01	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	6.63	8.17	7.91	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	8.12	11.42	12.08	0.66	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	7.79	10.74	11.58	0.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	46.74	8.13	16.26	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	51.53	14.92	14.24	3.39	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	56.96	11.39	9.32	4.14	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	60.23	14.39	17.59	2.67	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	78.27	13.40	18.23	3.75	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	60.37	27.38	29.48	3.51	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	60.40	7.06	14.90	3.14	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	61.96	10.55	9.23	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	40.27	37.81	30.41	4.11	0.00
CD19+ B Cells, donor2	11624-122B4	35.55	26.84	30.47	5.08	0.00
CD19+ B Cells, donor3	11705-123B4	36.35	26.25	22.72	6.06	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	14.95	23.44	17.37	2.83	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.59	13.98	9.59	2.00	0.80
CD34+ Progenitors, donor1	11545-120B6	27.11	19.08	20.08	9.04	0.00
CD34+ Progenitors, donor2	11625-122B5	46.07	16.29	24.16	2.81	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.48	16.53	21.42	6.76	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	68.32	20.29	16.91	11.50	0.23
CD4+ T Cells, donor1	11225-116C1	148.89	38.92	47.13	13.21	1.79
CD4+ T Cells, donor2	11306-117C1	65.52	19.60	41.03	7.35	1.84
CD4+ T Cells, donor3	11382-118B5	86.01	29.89	35.68	10.98	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	169.48	19.65	21.95	5.36	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	150.93	22.24	16.84	7.64	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	131.94	16.67	16.96	4.60	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	118.05	25.60	40.77	5.22	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	139.06	25.99	33.71	9.83	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	115.37	26.37	32.96	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	140.76	19.37	20.38	5.20	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	98.80	28.13	19.15	8.30	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	75.28	20.80	17.73	8.06	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	153.32	18.83	24.21	3.59	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	167.36	19.22	27.95	5.94	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	264.43	22.44	33.00	7.48	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	142.51	15.18	19.40	6.75	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	69.81	22.85	17.45	7.27	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	53.46	12.03	14.70	5.68	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	190.63	27.47	34.81	10.88	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	233.14	50.38	50.38	10.72	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	89.66	25.11	37.66	7.17	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	177.64	28.00	28.00	12.05	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	131.92	21.88	17.55	9.31	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	100.24	21.23	19.54	9.46	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	130.95	20.22	25.79	10.11	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	129.54	16.46	25.13	9.10	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	285.46	23.10	33.12	7.84	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	176.67	30.68	33.65	9.90	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	154.17	25.85	36.00	3.69	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	122.83	30.71	43.27	6.98	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	222.93	21.88	48.19	11.35	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	292.26	32.39	60.61	8.10	2.21
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	232.54	38.50	40.04	9.24	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	203.05	39.03	44.76	7.52	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	189.74	40.16	48.47	4.15	1.38
CD8+ T Cells, donor1	11226-116C2	100.51	29.47	48.45	7.86	0.65
CD8+ T Cells, donor2	11307-117C2	49.18	29.66	50.31	5.63	0.00
CD8+ T Cells, donor3	11383-118B6	78.27	48.73	60.09	10.86	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.40	11.70	9.86	5.96	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	22.53	7.67	10.78	4.55	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	26.54	13.95	9.85	4.92	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	33.62	10.51	12.01	3.30	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	23.52	15.12	10.32	4.32	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.42	12.05	9.32	4.78	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.03	9.13	11.95	5.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.01	10.26	11.32	4.47	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	28.14	12.66	10.79	4.69	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	34.41	9.66	11.47	3.62	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	30.50	10.75	9.30	6.39	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	32.24	13.85	13.06	10.39	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	31.96	14.01	15.32	7.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	32.34	15.94	15.94	10.47	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.02	34.31	32.07	20.14	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.53	10.80	11.16	6.48	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.44	12.08	14.10	5.47	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.91	12.49	9.66	4.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	41.20	6.02	7.29	4.75	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.84	10.76	8.30	4.61	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.98	12.18	13.46	6.73	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	28.30	15.68	11.47	5.74	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	29.16	9.85	16.16	4.73	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	8.32	11.35	3.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.89	11.24	12.85	3.21	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	34.27	13.29	11.89	5.60	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	16.03	15.03	5.01	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	20.11	21.93	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	12.35	3.95	2.47	2.47	0.49
Cardiac Myocyte, donor3	11686-122I3	19.26	5.47	3.68	1.79	0.42
Chondrocyte - de diff, donor1	11261-116G1	22.53	5.89	13.17	4.16	1.39
Chondrocyte - de diff, donor2	11338-117F6	5.69	2.49	3.91	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	8.65	4.21	3.64	1.59	0.23
Chondrocyte - re diff, donor2	11339-117F7	25.07	0.90	5.37	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	6.47	5.26	2.43	1.21	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	34.20	10.67	9.87	5.85	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	18.60	9.19	4.70	2.99	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	18.50	9.65	7.43	3.54	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	12.38	17.24	14.49	24.21	2.48
Corneal Epithelial Cells, donor1	11526-119I5	1.10	2.85	2.63	0.88	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	0.00	2.28	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	4.60	4.35	4.09	2.30	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.90	14.03	15.85	6.93	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	29.65	11.35	12.93	3.15	1.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	6.90	58.66	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.76	13.50	15.12	3.56	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	35.87	10.59	11.27	3.07	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	33.95	12.40	15.02	4.57	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.62	7.74	15.00	3.87	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	11.17	3.67	2.17	0.83	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	1.17	2.35	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	12.73	2.83	4.52	2.55	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.04	2.75	3.93	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	9.89	3.20	3.20	1.16	0.00
Endothelial Cells - Artery, donor2	11341-117F9	19.29	8.23	3.53	2.35	0.47
Endothelial Cells - Artery, donor3	11413-118E9	8.77	2.98	2.10	2.10	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	28.37	6.21	2.22	3.55	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.34	5.17	3.96	3.96	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	40.03	7.61	3.66	5.07	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	8.62	2.38	2.97	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	18.22	3.64	3.64	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	7.37	2.84	1.56	2.55	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	40.41	5.20	7.60	7.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	4.19	3.14	2.62	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	78.03	8.82	7.95	9.82	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	41.93	7.82	8.69	10.43	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	44.82	15.51	10.01	12.82	1.59
Endothelial Cells - Vein, donor1	11267-116G7	9.10	5.69	5.69	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.89	4.19	2.79	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	14.13	5.97	4.87	3.14	0.63
Eosinophils, donor1	12244-129H3	121.98	121.98	152.47	30.49	0.00
Eosinophils, donor2	12245-129H4	26.40	24.75	19.80	3.30	0.00
Eosinophils, donor3	12246-129H5	32.10	14.27	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.22	1.71	1.47	1.71	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	2.08	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.29	7.80	8.62	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.91	4.93	4.16	1.42	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.22	8.78	4.88	2.28	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.44	7.16	4.85	1.33	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	22.52	7.64	7.23	1.50	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.29	6.43	6.33	1.79	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.88	5.27	6.59	1.32	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	18.94	10.96	8.30	2.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	9.98	5.44	4.08	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	4.55	2.27	2.27	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.99	3.47	3.31	1.10	0.32
Fibroblast - Cardiac, donor4	11452-119A3	27.28	10.00	11.52	4.55	0.00
Fibroblast - Cardiac, donor5	11456-119A7	18.40	5.84	5.71	4.31	0.38
Fibroblast - Cardiac, donor6	11460-119B2	24.56	5.91	3.18	2.88	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.91	3.08	5.63	1.34	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.81	7.33	4.31	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	5.86	4.39	4.39	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	5.30	7.15	8.30	3.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	38.84	6.95	7.80	3.05	0.68
Fibroblast - Dermal, donor1	11269-116G9	9.63	6.34	6.81	2.35	0.47
Fibroblast - Dermal, donor2	11346-117G5	13.21	2.83	1.89	1.89	0.94
Fibroblast - Dermal, donor3	11418-118F5	13.78	7.49	6.65	2.30	0.85
Fibroblast - Dermal, donor4	11450-119A1	29.62	11.98	9.38	5.77	1.13
Fibroblast - Dermal, donor5	11454-119A5	33.32	13.61	13.08	4.71	1.57
Fibroblast - Dermal, donor6	11458-119A9	41.26	14.62	9.75	7.80	1.30
Fibroblast - Gingival, donor1	11237-116D4	31.23	6.87	3.75	2.71	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.06	13.10	7.60	2.62	0.26
Fibroblast - Gingival, donor2	11318-117D4	30.71	10.28	6.19	3.16	1.45
Fibroblast - Gingival, donor3	11394-118C8	23.78	13.05	9.19	3.29	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	9.35	8.31	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.40	9.34	7.22	2.29	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.85	11.54	8.11	3.90	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	32.73	11.09	8.52	3.25	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.59	52.58	29.29	18.35	4.94
Fibroblast - Gingival, donor7 (control)	11924-125H7	23.84	15.21	9.36	4.97	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	30.13	10.36	8.04	3.41	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.09	22.60	15.47	6.80	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	23.33	12.03	10.42	2.49	0.88
Fibroblast - Lung, donor1	11270-116H1	2.72	2.72	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	8.95	8.95	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	12.03	8.86	4.85	3.17	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	3.33	8.33	5.83	2.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	1.40	8.39	0.00	4.20
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	1.68	1.96	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	9.34	10.96	6.50	4.47	1.22
Fibroblast - Mammary, donor2	11620-122A9	0.00	15.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	11.91	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	44.03	12.61	6.01	6.60	1.75
Fibroblast - Periodontal Ligament, donor2	11319-117D5	42.47	20.63	11.98	6.52	2.43
Fibroblast - Periodontal Ligament, donor3	11395-118C9	50.49	18.97	14.99	7.34	3.37
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	20.61	14.88	12.21	3.43	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.50	9.99	7.83	1.62	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	10.09	11.37	7.42	3.60	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.96	4.20	4.09	1.55	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.91	10.77	8.13	3.45	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.68	8.02	3.34	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	15.42	3.56	1.19	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	31.75	11.51	10.12	3.37	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.41	4.44	7.28	1.42	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	20.69	6.31	8.47	1.58	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	20.16	7.22	10.53	1.20	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	29.15	7.45	10.04	2.81	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.97	8.35	6.83	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	16.41	10.34	7.22	1.64	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	34.89	11.23	8.02	3.41	1.40
Fibroblast - skin normal, donor2	11561-120D4	25.52	6.63	8.74	1.61	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	32.04	6.65	11.79	2.12	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	21.79	8.28	7.54	2.15	0.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	38.12	7.01	7.35	1.20	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.33	9.20	11.17	3.61	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.43	7.88	7.56	3.41	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	12.82	8.10	5.90	1.35	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.19	8.47	6.90	1.25	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	376.72	177.28	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	22.66	19.17	3.49	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.61	6.59	5.89	2.25	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	17.18	10.15	6.77	2.08	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.82	10.73	9.45	2.81	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	18.37	14.55	16.08	3.06	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	28.08	19.14	12.76	9.57	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	60.48	26.24	18.26	11.13	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	38.88	45.78	20.96	28.13	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.23	28.31	19.18	16.21	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	34.67	30.51	17.04	16.44	3.57
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	29.08	43.09	21.15	27.23	4.23
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	30.33	40.44	26.74	25.44	4.57
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	46.43	23.44	21.23	11.50	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	48.90	15.12	9.19	11.59	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	30.42	19.95	13.18	14.28	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	37.07	13.70	9.13	7.79	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	36.55	17.10	8.92	11.40	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	41.39	14.53	8.03	12.74	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	45.54	12.60	8.74	9.15	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	33.31	17.34	10.27	7.99	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	40.11	13.83	8.10	10.96	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	43.28	15.30	8.74	10.05	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.32	15.07	12.11	7.39	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.00	16.37	13.51	11.76	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	31.95	17.65	11.62	9.38	2.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.86	18.75	13.11	10.28	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	43.94	17.13	11.37	10.18	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	65.79	16.76	14.45	10.11	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.60	23.72	17.07	16.96	2.39
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	78.90	19.64	14.17	10.93	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.53	17.48	12.39	10.29	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.33	17.97	14.56	9.23	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	53.70	14.70	13.07	5.72	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	40.02	13.41	10.93	9.70	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	33.44	19.25	14.53	11.07	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.02	19.01	9.34	8.34	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.89	17.41	10.58	12.12	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	36.16	18.20	12.42	10.09	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.36	17.67	10.70	10.54	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.28	19.56	12.19	8.02	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.94	14.12	9.19	8.34	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.73	13.44	8.23	7.59	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	35.27	14.60	11.56	6.69	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	30.73	12.65	7.84	9.30	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	24.37	10.10	8.78	7.03	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	29.74	15.43	10.66	6.73	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.11	14.44	9.54	8.43	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.07	12.84	9.89	6.69	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.07	14.23	11.17	5.51	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	18.01	11.92	7.25	7.64	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	25.21	16.81	13.82	5.42	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.57	13.83	7.56	4.42	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	29.83	10.31	6.80	4.82	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	43.64	45.62	24.79	21.82	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.85	13.59	8.44	4.88	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.57	10.29	7.26	3.23	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	57.19	25.42	18.81	14.74	3.81
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	85.99	12.34	16.32	13.14	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	44.07	21.11	12.48	13.87	3.24
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	57.90	31.91	15.96	19.23	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	17.21	7.82	6.88	7.82	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	19.78	14.69	6.50	5.93	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.50	17.53	11.99	9.22	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	54.45	29.70	7.42	7.42	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	47.96	26.30	7.74	5.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	28.88	11.23	19.25	6.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	19.13	17.39	17.39	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	37.43	20.18	13.02	7.49	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	58.48	17.30	13.59	9.06	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	29.99	10.00	16.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	38.31	17.62	11.19	7.55	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	34.65	17.98	13.07	8.50	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	36.91	26.84	16.78	15.10	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.03	20.36	13.36	11.45	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	34.99	18.34	10.19	6.79	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	22.97	8.35	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	37.23	22.34	12.03	9.74	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	17.17	16.58	6.81	5.33	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	42.35	18.64	8.47	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	37.28	16.57	9.11	8.70	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.45	18.41	12.89	9.44	2.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	42.15	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.52	18.07	6.54	8.07	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	27.38	18.58	11.73	9.13	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	27.42	22.74	12.04	11.37	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	39.30	24.66	12.33	8.48	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	30.13	33.55	22.25	10.27	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	37.27	12.42	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	43.41	34.92	17.93	11.80	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.38	22.33	10.86	13.88	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.15	31.03	21.36	19.33	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	33.90	26.32	13.56	11.97	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	38.48	23.19	13.32	8.88	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	20.07	35.41	21.25	9.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	23.92	19.25	11.09	8.17	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	36.43	22.82	12.29	13.17	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	27.97	13.56	11.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.36	12.54	10.74	7.76	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.20	15.04	11.65	3.40	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	5.71	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.07	4.57	4.57	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2.25	1.12	4.50	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.20	5.71	3.49	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.35	3.34	2.51	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	11.60	4.87	3.48	1.86	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.18	4.39	4.56	1.35	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.24	5.92	3.19	1.82	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.48	3.83	3.83	1.53	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.67	5.37	4.73	2.15	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	9.47	3.88	2.58	1.94	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.22	4.36	3.99	1.74	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	11.32	4.97	3.26	1.72	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.61	3.84	4.16	0.96	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5.60	3.36	4.48	3.36	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	0.43	3.90	4.33	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	10.58	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.23	2.12	2.47	1.41	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	2.91	2.91	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.53	3.85	3.50	1.05	0.17
Hepatocyte, donor1	11523-119I2	9.68	3.63	3.63	1.21	0.00
Hepatocyte, donor2	11603-120I1	8.62	8.62	8.62	0.00	1.08
Hepatocyte, donor3	11684-122I1	7.36	1.84	3.68	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	56.13	22.84	17.62	16.97	3.92
Intestinal epithelial cells (polarized), donor1	11246-116E4	30.06	8.04	11.71	3.85	1.57
Iris Pigment Epithelial Cells, donor1	11530-119I9	23.05	8.10	3.57	2.06	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	35.02	22.29	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	26.70	13.35	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	35.99	16.61	8.31	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	22.52	15.02	15.02	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	23.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	35.88	28.19	15.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	50.28	13.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	40.61	17.87	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	15.01	5.00	6.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	29.04	21.78	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	22.50	27.79	5.29	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	14.41	17.74	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	36.67	10.48	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.67	23.30	13.86	2.52	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	26.29	23.20	4.64	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	58.54	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.29	36.18	12.27	9.69	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	38.64	19.32	14.49	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	119.48	83.64	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	3.26	33.41	12.22	7.33	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.78	12.17	5.46	6.72	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	6.43	28.93	14.47	10.45	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	22.16	9.23	3.69	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16	75.40	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	17.94	7.08	6.61	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	14.51	15.42	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	14.74	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	25.83	11.84	11.84	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	30.49	12.70	6.35	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.10	26.14	8.29	11.48	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	25.52	16.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	110.63	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.14	30.70	8.57	4.28	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	43.14	13.27	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	83.39	62.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.70	20.68	10.19	5.56	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	33.36	22.83	8.78	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	47.15	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	29.21	8.34	11.82	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	50.90	17.70	6.64	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	29.18	16.21	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	30.52	18.31	9.59	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	38.25	15.75	9.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	17.42	13.94	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	27.74	9.60	6.40	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	22.17	16.63	12.47	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	34.20	19.95	5.70	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	34.98	9.20	10.12	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	24.20	9.08	12.10	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	24.83	31.04	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	23.26	16.92	4.23	1.06
Keratinocyte - epidermal, donor1	11272-116H3	15.34	9.22	8.49	1.39	0.24
Keratinocyte - epidermal, donor2	11349-117G8	3.51	3.51	2.93	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	20.92	8.80	9.37	3.03	0.76
Keratinocyte - oral, donor1	11251-116E9	49.72	11.12	8.29	3.63	1.25
Keratocytes, donor1	11527-119I6	6.88	3.78	6.88	2.06	0.69
Keratocytes, donor2	11607-120I5	4.69	5.86	4.69	1.17	0.00
Keratocytes, donor3	11688-122I5	16.20	11.26	15.21	2.77	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	15.39	13.19	15.39	0.00
Lens Epithelial Cells, donor1	11529-119I8	28.05	12.94	6.47	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	33.68	9.00	7.84	5.31	1.96
Lens Epithelial Cells, donor3	11690-122I7	29.97	10.49	6.66	4.44	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.70	4.15	2.13	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.42	2.79	1.67	2.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.82	3.31	3.15	1.73	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.91	0.00	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.04	2.52	1.58	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.25	3.02	0.75	1.29	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.67	3.28	3.69	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.28	1.77	0.76	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.59	1.27	1.97	1.69	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	16.61	1.98	1.98	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.44	5.62	2.52	1.16	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.52	1.48	0.37	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.50	2.79	1.74	1.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.92	1.91	1.67	1.43	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.46	1.37	1.79	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	13.55	2.16	1.85	2.46	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.12	1.56	1.56	1.25	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.22	1.65	2.20	0.73	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.85	3.29	1.97	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.81	1.76	0.88	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2.74	2.24	1.49	0.75	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	18.43	1.94	2.42	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.66	3.50	2.42	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.63	1.82	1.97	1.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.81	0.52	1.04	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.84	2.72	1.88	2.30	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.86	2.26	1.80	1.65	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.20	3.44	2.06	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.60	2.07	1.13	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.67	2.54	1.17	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	5.33	1.94	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.28	2.65	1.65	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.69	0.87	0.87	1.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.14	4.44	3.33	2.22	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.65	2.47	1.73	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.22	1.37	1.24	1.79	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.44	3.86	1.29	3.22	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.39	3.04	5.48	1.83	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	15.12	3.22	2.10	1.96	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.22	2.49	2.84	2.13	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	1.45	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.36	1.09	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.31	2.86	1.07	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.17	3.59	2.94	1.31	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.00	1.88	0.94	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.73	2.97	2.23	1.73	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.63	2.56	1.02	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.55	1.79	1.19	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	2.27	9.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.14	9.97	5.37	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.97	5.94	2.97	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.19	5.08	4.65	2.54	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.11	4.92	6.33	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	4.67	3.74	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	5.15	2.06	2.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1.19	4.76	4.76	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.11	4.07	3.39	0.68	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	8.72	6.40	6.98	2.33	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.10	6.30	5.40	3.15	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.08	4.47	6.77	2.44	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.62	8.22	7.19	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.35	5.65	7.41	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.99	4.66	8.00	1.33	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.15	8.15	8.15	2.04	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	9.87	8.54	6.67	2.93	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.58	6.80	6.42	2.46	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.98	8.59	4.91	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.15	9.79	7.34	4.89	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.00	7.71	7.08	2.29	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.73	7.01	8.13	1.68	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	10.30	8.24	9.27	7.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	8.42	6.10	4.35	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.16	9.27	7.17	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	15.49	6.09	5.53	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	8.13	7.42	5.30	1.41	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	10.33	9.22	7.74	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	5.76	6.91	2.30	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.98	10.36	7.68	1.54	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.72	8.49	8.49	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.85	2.46	6.56	1.64	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	7.68	8.59	7.23	1.36	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	5.75	7.18	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	7.47	8.96	13.44	2.24	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6.69	6.32	5.57	1.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.92	6.46	6.03	2.15	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	11.13	5.14	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.66	7.00	5.00	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.07	6.03	6.64	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	3.55	7.11	3.55	2.13	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.25	5.16	4.47	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.10	7.51	5.37	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5.39	4.71	5.39	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7.04	5.93	4.07	2.96	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	9.30	5.81	5.81	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	5.29	3.17	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	11.60	6.40	4.00	3.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	6.54	7.27	8.72	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	7.67	2.30	6.13	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	5.92	4.44	3.95	2.96	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	5.65	4.70	4.70	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.03	7.54	3.52	2.51	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.81	6.31	6.31	4.06	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	10.33	5.16	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.13	5.79	9.35	2.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	11.34	6.26	6.65	3.52	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	8.58	4.62	11.22	2.64	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	5.19	6.23	4.67	4.15	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	6.13	11.38	5.69	4.38	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.98	7.83	6.15	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	6.62	8.39	3.53	1.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.56	10.41	7.33	3.09	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	7.09	6.58	9.62	2.03	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.53	4.81	6.73	0.96	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	6.76	5.96	3.18	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.33	4.86	10.33	2.43	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	3.46	10.38	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	9.50	4.56	8.36	2.66	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	7.23	9.81	9.30	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	2.42	8.47	3.02	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.56	8.87	6.97	1.90	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	7.46	12.26	10.13	2.67	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	5.75	8.05	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.37	8.23	9.26	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	8.49	9.20	7.07	4.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	6.81	7.94	3.40	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.32	11.23	5.82	1.25	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.05	3.92	11.75	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.93	2.92	6.68	2.09	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.36	6.50	8.36	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	4.68	8.70	8.03	1.34	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.16	6.42	11.23	3.21	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.89	7.68	9.70	3.23	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	8.26	7.34	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	10.67	4.45	11.56	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.98	9.69	13.68	3.99	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	11.50	10.74	6.14	3.83	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.13	4.92	10.94	3.83	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.02	9.80	6.68	4.01	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.58	9.36	6.76	2.60	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.96	2.65	9.28	2.65	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	8.31	2.08	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	15.73	5.24	6.38	1.37	0.23
Macrophage - monocyte derived, donor2	11313-117C8	19.08	6.06	7.16	2.39	0.73
Macrophage - monocyte derived, donor3	11389-118C3	14.94	11.54	8.52	3.41	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.37	2.66	2.66	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	24.24	6.34	7.76	1.90	0.48
Mallassez-derived cells, donor3	11930-125I4	24.88	6.95	9.45	1.53	0.42
Mammary Epithelial Cell, donor1	11273-116H4	48.03	13.15	13.85	2.79	0.80
Mammary Epithelial Cell, donor2	11350-117G9	37.35	10.13	8.69	4.92	0.87
Mammary Epithelial Cell, donor3	11422-118F9	3.24	5.74	3.99	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	118.64	8.81	10.17	4.07	0.00
Mast cell, donor1	11563-120D6	44.01	6.60	6.49	3.24	0.32
Mast cell, donor2	11565-120D8	31.20	7.73	6.54	0.30	0.30
Mast cell, donor3	11566-120D9	36.47	6.08	7.43	2.48	0.45
Mast cell, donor4	11567-120E1	24.11	5.67	6.03	1.60	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	38.59	7.87	9.20	2.66	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	31.52	4.09	4.67	7.00	0.00
Mast cell, expanded, donor5	11939-126A4	37.86	7.92	6.31	2.64	0.34
Mast cell, expanded, donor8	11941-126A6	41.00	7.87	8.54	3.18	0.50
Melanocyte - dark, donor1	11502-119F8	37.31	4.97	3.48	4.28	0.80
Melanocyte - dark, donor2	11582-120F7	14.54	3.46	1.73	1.04	0.35
Melanocyte - dark, donor3	11663-122F7	36.87	14.56	14.34	4.64	1.59
Melanocyte - light, donor1	11274-116H5	3.29	6.82	4.00	1.41	0.47
Melanocyte - light, donor2	11351-117H1	2.73	2.73	2.05	0.68	0.68
Melanocyte - light, donor3	11423-118G1	2.60	6.07	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	19.47	10.93	9.06	3.33	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	16.41	6.45	7.26	2.42	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	20.62	13.39	12.05	3.48	1.34
Meningeal Cells, donor1	11493-119E8	12.90	7.07	8.93	3.23	0.87
Meningeal Cells, donor2	11573-120E7	4.84	7.92	15.85	1.76	1.76
Meningeal Cells, donor3	11654-122E7	46.37	10.92	10.51	4.48	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	30.80	6.56	5.99	3.42	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	18.52	7.04	5.74	2.01	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	6.57	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	2.62	2.62	0.00	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.05	3.59	4.31	3.59	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	16.52	5.72	5.72	2.12	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8.54	10.56	8.04	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	6.59	2.42	3.08	3.08	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	8.04	2.92	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2.66	6.34	2.25	1.43	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	31.03	2.91	5.68	1.52	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.72	0.37	1.86	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	34.08	3.82	6.84	0.92	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.56	1.48	3.56	0.89	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	4.48	3.84	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.52	4.96	3.90	3.19	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	27.52	4.38	4.69	2.81	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	14.51	5.81	3.63	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	10.61	7.96	3.71	2.12	0.00
Mesothelial Cells, donor2	12156-128G5	5.51	5.00	5.00	2.00	1.50
Mesothelial Cells, donor3	11402-118D7	9.54	6.29	4.55	2.02	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	37.81	32.41	13.50	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.69	17.98	17.49	1.97	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.37	17.08	15.61	3.83	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	41.48	13.83	10.37	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.85	11.16	8.99	2.79	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.41	10.79	11.41	2.90	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	18.53	20.84	9.26	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.51	13.26	10.26	2.50	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.03	20.95	20.48	6.05	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	13.82	10.97	11.58	3.05	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.48	11.09	14.25	2.38	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	25.65	94.07	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	3.54	3.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	11.78	9.50	5.32	3.04	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	11.84	3.95	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.61	5.31	7.85	1.06	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	17.50	11.97	6.45	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.15	6.26	7.75	1.49	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	23.47	26.83	16.77	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.28	4.77	7.03	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.74	10.22	11.88	2.85	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	2.21	5.53	1.11	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.98	4.14	4.60	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.31	8.83	8.83	2.73	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.95	6.32	6.93	2.24	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.94	6.22	4.51	1.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.00	11.78	8.67	4.22	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	20.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.32	3.50	5.04	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	12.17	9.13	5.07	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	18.23	3.31	1.66	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.87	5.98	7.61	1.90	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.23	7.65	8.23	4.12	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	11.99	4.36	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.88	3.84	4.81	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.81	4.00	7.60	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	17.83	9.60	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.50	6.51	7.01	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	18.35	16.31	6.12	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.01	3.94	3.94	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	11.04	15.45	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	16.01	13.45	3.84	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.16	3.22	5.21	0.99	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	11.13	8.35	3.48	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	28.73	26.52	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	17.44	4.10	5.81	0.34	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.07	10.50	10.94	4.38	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	13.85	11.72	3.20	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.75	3.93	3.93	1.68	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.31	9.56	6.23	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.82	22.14	16.90	2.33	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.26	5.43	8.14	1.51	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.03	7.93	2.50	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	14.44	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	2.77	5.54	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.66	10.24	9.68	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.64	7.88	6.22	2.21	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.11	3.11	3.37	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	14.59	13.30	10.72	3.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	16.51	10.16	1.91	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.54	9.87	5.34	2.14	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.47	11.37	13.17	2.69	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.20	9.89	7.63	2.54	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.51	3.82	4.14	0.96	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.58	10.84	7.52	1.77	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.24	18.20	9.86	3.03	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.51	4.55	6.53	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.22	8.60	7.87	1.23	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.26	22.81	21.51	5.21	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	8.82	10.29	7.64	1.47	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.13	8.07	10.38	3.17	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.37	11.13	8.66	2.06	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.23	11.32	6.55	3.87	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	1.78	5.35	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.59	8.21	4.93	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	7.36	3.16	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	9.49	3.95	2.37	1.38	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	8.38	6.52	4.66	5.59	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.64	9.01	5.63	2.25	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.26	6.66	6.39	2.93	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.18	2.38	3.05	0.90	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.95	1.47	1.47	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.13	7.69	5.13	2.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	4.67	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	7.48	1.07	4.28	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3.03	9.09	5.05	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.22	5.90	5.90	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	4.09	10.90	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	4.05	3.24	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	10.57	15.10	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	11.42	39.97	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	16.31	16.31	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	4.75	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	37.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.96	4.74	4.09	1.08	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	15.16	6.79	8.88	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	26.03	24.03	6.01	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.77	36.31	26.29	5.01	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	46.39	37.84	16.73	7.80	1.90
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	70.22	30.32	14.36	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	17.68	14.96	2.72	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	108.42	71.67	34.92	7.35	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	26.37	13.39	1.67	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.16	26.96	18.83	3.25	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.89	31.89	20.81	5.67	2.70
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	18.08	18.08	10.93	4.84	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	211.56	167.02	89.08	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.88	8.44	4.47	2.98	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.24	18.68	11.10	2.71	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.48	17.45	13.15	3.40	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.82	26.94	17.47	6.70	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.68	11.85	8.93	3.46	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.91	11.14	9.55	2.12	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	12.01	10.21	4.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	66.29	25.93	15.42	4.92	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.83	26.02	16.91	5.37	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	26.28	29.81	22.22	8.64	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.81	19.69	21.10	4.92	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	29.88	17.47	4.60	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.39	20.24	16.39	3.86	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	45.18	24.83	20.69	4.48	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	161.82	136.54	134.01	7.59	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.93	27.85	18.94	6.68	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.77	29.21	23.71	1.69	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.82	31.57	14.00	3.80	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.45	24.47	16.74	3.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	334.03	72.22	99.31	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.00	16.66	15.66	4.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	38.32	26.15	7.21	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.16	19.05	19.84	1.59	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	19.50	14.86	1.86	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.59	20.05	14.76	4.54	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.43	20.20	16.95	1.96	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	21.35	21.35	6.10	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	30.76	27.14	5.88	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	22.05	16.76	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.97	23.27	13.96	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.39	16.87	9.92	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.89	24.12	21.82	4.59	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	10.89	16.33	14.82	2.72	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	14.15	19.23	15.91	3.98	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	21.01	19.65	2.03	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	107.30	66.42	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	14.02	13.41	1.83	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.44	22.03	14.48	3.78	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.08	42.98	33.29	5.45	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	13.45	15.82	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	55.55	35.14	29.47	5.67	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	126.45	65.75	65.75	5.06	5.06
Myoblast, donor1	11241-116D8	14.41	4.72	6.21	0.99	0.50
Myoblast, donor2	11322-117D8	14.00	8.44	8.25	1.73	1.73
Myoblast, donor3	11398-118D3	21.19	10.76	7.40	2.19	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	76.03	49.62	58.96	10.51	1.46
Natural Killer Cells, donor1	11230-116C6	115.63	27.98	40.28	6.15	0.62
Natural Killer Cells, donor2	11311-117C6	56.69	23.52	33.77	5.43	0.30
Natural Killer Cells, donor3	11387-118C1	55.22	27.61	45.65	5.89	0.74
Neural stem cells, donor1	11275-116H6	109.97	25.77	20.69	15.97	2.18
Neural stem cells, donor2	11352-117H2	138.65	53.92	36.59	30.81	1.93
Neurons, donor1	11494-119E9	56.89	31.86	23.90	15.93	0.00
Neurons, donor2	11574-120E8	78.16	29.50	18.71	18.93	3.30
Neurons, donor3	11655-122E8	46.04	50.97	18.09	27.95	1.64
Neutrophils, donor1	11233-116C9	32.48	17.63	29.70	2.78	0.00
Neutrophils, donor2	11314-117C9	26.09	37.69	20.29	2.90	0.00
Neutrophils, donor3	11390-118C4	59.86	80.02	64.75	7.33	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	34.91	5.82	5.58	0.71	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	8.47	4.88	2.60	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	14.04	4.41	6.62	1.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	8.40	8.12	6.06	2.75	0.14
Olfactory epithelial cells, donor2	11934-125I8	13.46	9.12	5.21	2.32	0.43
Olfactory epithelial cells, donor3	11935-125I9	10.44	9.31	4.88	2.04	0.45
Olfactory epithelial cells, donor4	11936-126A1	13.64	19.38	11.79	5.06	1.17
Oligodendrocyte - precursors, donor1	11496-119F2	30.69	9.63	7.82	5.42	0.00
Osteoblast - differentiated, donor1	11276-116H7	10.63	4.89	3.62	1.70	0.21
Osteoblast - differentiated, donor2	11353-117H3	5.72	3.43	3.43	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	5.59	2.48	6.21	0.62	0.62
Osteoblast, donor1	11277-116H8	1.37	1.76	1.37	0.39	0.00
Osteoblast, donor2	11354-117H4	36.52	11.24	7.73	5.62	0.70
Osteoblast, donor3	11426-118G4	8.89	8.18	4.27	1.07	0.89
Pancreatic stromal cells, donor1	11249-116E7	28.64	8.51	6.40	2.27	0.34
Pericytes, donor1	11491-119E6	2.78	0.78	1.78	0.33	0.00
Pericytes, donor2	11571-120E5	2.04	3.62	5.21	1.58	0.68
Pericytes, donor3	11652-122E5	3.05	3.66	1.83	1.22	0.00
Perineurial Cells, donor1	11499-119F5	30.06	6.78	5.09	1.81	1.13
Perineurial Cells, donor2	11579-120F4	28.62	5.70	5.34	3.22	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	133.55	44.62	55.46	11.16	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	45.05	27.42	33.30	3.43	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.21	34.55	36.88	7.25	1.42
Placental Epithelial Cells, donor1	11278-116H9	1.43	1.67	0.96	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	7.76	0.00	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.93	3.34	0.20	0.98	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.49	5.38	3.80	1.27	0.32
Preadipocyte - breast, donor1	11467-119B9	13.32	4.69	4.69	0.75	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.53	8.88	3.79	0.91	0.13
Preadipocyte - breast, donor2	11328-117E5	9.01	4.50	5.63	1.58	0.00
Preadipocyte - omental, donor1	11468-119C1	15.02	5.54	6.93	1.70	0.32
Preadipocyte - omental, donor2	11329-117E6	10.91	9.60	3.93	2.18	0.44
Preadipocyte - omental, donor3	11403-118D8	13.18	7.59	5.44	1.29	0.43
Preadipocyte - perirenal, donor1	11469-119C2	0.98	2.95	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	3.69	2.46	2.76	1.23	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	24.26	10.45	7.97	3.54	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	14.81	6.64	5.62	2.38	0.85
Preadipocyte - visceral, donor1	11280-116I2	37.72	10.06	8.48	2.98	0.75
Preadipocyte - visceral, donor2	11357-117H7	28.07	8.74	5.06	2.30	0.46
Preadipocyte - visceral, donor3	11429-118G7	18.39	5.85	6.69	2.72	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	38.77	12.82	11.16	3.62	0.30
Prostate Epithelial Cells, donor2	11331-117E8	7.99	5.42	5.28	0.68	0.27
Prostate Epithelial Cells, donor3	11404-118D9	17.33	8.51	6.86	3.61	0.55
Prostate Stromal Cells, donor1	11254-116F3	17.31	8.09	4.44	1.37	0.23
Prostate Stromal Cells, donor2	11332-117E9	12.01	8.25	10.40	3.59	0.72
Prostate Stromal Cells, donor3	11405-118E1	9.28	5.63	4.28	1.46	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.11	4.38	3.28	1.09	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	35.63	7.07	5.13	2.77	0.83
Renal Epithelial Cells, donor1	11517-119H5	1.52	4.06	4.57	3.55	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.85	9.25	0.71	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	52.19	10.48	6.46	5.72	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	0.68	4.77	2.04	2.72	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	3.64	2.29	4.58	1.89	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.42	14.21	6.22	7.55	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	7.32	3.99	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.06	4.40	2.42	1.98	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.02	4.39	3.76	2.51	0.63
Renal Mesangial Cells, donor3	11679-122H5	2.50	2.50	1.39	1.66	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.32	6.71	6.44	4.03	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1.69	4.64	2.53	3.37	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	4.44	7.14	3.09	2.70	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.56	7.00	6.22	3.37	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	4.83	5.12	4.83	2.27	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	8.23	8.23	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.34	4.52	5.52	3.51	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	46.51	46.10	41.69	6.82	2.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	35.74	29.48	14.29	7.15	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	66.59	20.36	21.46	2.75	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	111.37	41.18	31.90	8.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	43.69	14.69	21.71	11.05	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.83	25.72	15.09	10.43	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	33.13	23.31	13.94	8.37	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	41.80	17.86	17.86	8.93	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	22.96	24.24	13.99	8.86	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	43.45	27.27	18.72	10.63	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	23.27	19.30	18.21	9.04	3.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	30.41	24.20	14.52	9.98	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	26.16	22.58	16.66	10.03	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	20.80	17.79	17.79	7.89	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	22.00	20.39	15.78	8.69	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	25.45	23.68	17.04	9.29	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	33.46	21.79	22.18	8.79	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.53	27.02	18.35	13.23	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	44.53	27.06	24.43	9.21	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	27.87	23.89	26.01	14.20	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	23.95	27.26	21.32	12.65	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	30.36	28.45	18.90	10.50	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	27.02	18.05	23.07	9.61	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	27.47	23.55	15.70	10.09	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.10	23.58	17.77	11.45	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	19.69	16.59	23.52	8.75	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	18.76	21.34	15.94	8.95	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	23.24	23.24	16.12	9.13	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.25	12.74	16.75	6.13	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	17.66	23.61	19.25	11.11	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	24.32	23.38	18.24	8.65	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	24.68	16.80	16.17	8.29	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	24.78	20.13	15.26	5.97	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	20.26	35.51	18.80	12.12	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.40	19.38	20.59	9.82	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	21.97	39.85	28.44	17.54	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.06	37.98	22.17	11.57	2.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	36.45	17.88	16.68	7.91	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.87	34.98	24.00	15.36	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	40.06	29.22	17.57	10.18	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	33.57	19.94	22.16	9.54	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.19	23.67	19.09	10.36	3.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	30.12	45.31	16.53	11.99	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	28.34	15.90	22.26	10.78	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	28.10	19.29	14.05	7.14	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	43.33	55.63	34.67	13.91	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.64	14.03	16.01	7.35	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	38.78	23.76	23.06	11.53	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	27.20	25.08	19.34	6.04	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	28.15	18.11	16.16	6.98	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	67.25	37.84	35.51	17.32	4.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.64	24.95	15.82	7.91	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	28.93	18.69	16.58	7.84	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	28.95	25.56	19.68	9.95	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	30.25	34.75	19.47	10.78	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	33.42	9.80	13.22	6.49	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	26.68	23.69	20.70	9.39	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.65	35.46	17.43	8.41	3.00
Schwann Cells, donor1	11498-119F4	3.57	4.51	5.45	1.88	0.56
Schwann Cells, donor2	11578-120F3	17.01	10.21	3.40	3.40	0.00
Schwann Cells, donor3	11659-122F3	14.46	5.48	3.51	2.63	0.44
Sebocyte, donor1	11220-116B5	7.67	4.38	7.67	3.29	1.10
Sebocyte, donor2	11301-117B5	5.51	9.65	9.19	1.84	0.46
Sebocyte, donor3	11378-118B1	3.92	4.95	3.92	1.44	0.00
Sertoli Cells, donor1	11255-116F4	18.22	4.97	8.28	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	2.82	11.30	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	21.91	9.24	9.59	4.93	0.62
Skeletal Muscle Cells, donor2	11358-117H8	4.34	2.89	5.06	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	3.34	5.85	2.51	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	21.84	5.97	8.48	2.83	0.00
Skeletal Muscle Cells, donor5	11455-119A6	17.39	8.92	7.28	3.12	0.59
Skeletal Muscle Cells, donor6	11459-119B1	29.09	10.00	8.31	3.85	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	43.35	7.06	6.43	3.78	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	19.69	8.13	5.71	2.14	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.52	14.88	9.72	5.36	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.75	9.44	13.23	4.47	1.26
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	6.51	1.45	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.95	2.75	2.06	1.24	0.28
Skin - palm, donor1	10286-104F7	34.92	29.55	26.86	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.64	6.20	5.33	1.30	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	71.16	12.27	17.99	3.27	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.17	11.29	6.23	1.56	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	23.77	4.45	7.37	2.78	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	16.88	10.55	11.96	3.09	1.55
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	51.38	16.28	15.44	3.81	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	12.29	14.39	13.87	5.17	1.27
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.03	7.10	6.17	1.54	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	21.57	3.78	7.56	3.33	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	9.99	3.53	5.88	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.18	6.19	4.64	1.33	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.36	2.76	1.58	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.04	2.32	7.73	0.77	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	21.02	0.00	6.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.46	3.99	2.26	1.33	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.53	6.87	4.88	1.33	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.21	2.30	3.46	1.02	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.88	5.21	6.19	1.95	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.85	10.34	4.73	1.18	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.25	5.13	4.27	2.56	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	0.98	2.60	2.11	1.14	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	13.09	10.05	9.13	2.44	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.82	7.58	4.04	2.02	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.25	2.86	2.38	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	25.22	5.75	3.54	1.92	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.33	7.53	3.23	0.65	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.64	7.66	5.56	1.47	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.71	1.70	2.94	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	0.00	4.31	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.48	5.08	2.69	1.49	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.07	2.39	1.71	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	36.83	4.48	4.32	1.96	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.30	7.25	4.73	2.31	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.74	6.14	6.83	1.37	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	1.81	3.02	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	49.28	12.45	12.19	6.89	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	24.50	6.26	9.32	3.46	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	13.65	7.14	6.14	3.38	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	9.89	4.06	3.55	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	15.23	5.88	5.88	1.21	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	6.00	3.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	27.14	0.00	19.38	12.92	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	8.84	11.16	3.72	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.06	3.53	2.52	2.52	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.64	8.78	5.33	2.19	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.36	1.18	0.88	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.90	11.41	8.66	5.66	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.48	3.27	2.34	1.87	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.75	2.16	2.45	0.43	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	6.37	3.31	4.08	0.51	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.70	4.32	3.01	0.94	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	43.74	9.36	7.13	4.89	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	30.67	5.61	4.36	1.84	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	5.71	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.65	1.96	3.91	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	17.01	8.18	10.16	3.31	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	22.53	7.90	3.22	1.17	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.11	7.19	7.19	1.94	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.99	8.20	7.40	1.59	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	24.92	4.09	4.84	0.37	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.17	10.78	5.39	1.44	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.95	5.96	6.53	1.42	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.45	10.24	7.88	3.54	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	16.76	7.87	5.84	2.29	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	12.38	13.18	4.79	3.19	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	8.36	7.94	3.34	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.38	4.13	4.58	1.83	0.46
Synoviocyte, donor1	11291-117A4	11.95	5.22	5.55	1.01	0.50
Synoviocyte, donor2	11368-117I9	10.73	4.86	4.36	0.50	0.17
Synoviocyte, donor3	11440-118H9	8.04	5.59	7.82	1.79	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	7.86	8.22	3.22	2.50	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	3.96	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.79	6.48	5.56	1.62	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	13.76	3.87	3.80	0.79	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	3.48	3.48	1.93	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	4.58	8.02	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.21	42.07	38.14	10.58	1.85
Urethra, donor2	10319-105A4	34.17	52.15	73.74	14.39	0.00
Urothelial Cells, donor1	11520-119H8	2.13	2.39	3.45	0.80	0.80
Urothelial Cells, donor2	11600-120H7	2.80	5.61	2.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	1.60	5.04	3.67	1.38	0.00
Urothelial cells, donor0	11216-116B1	32.54	12.93	7.36	4.46	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	202.87	188.63	322.99	16.02	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	151.54	187.28	300.22	14.30	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	69.14	280.65	271.07	9.58	4.11
Whole blood (ribopure), donor090325, donation1	12176-128I7	123.96	143.93	149.79	7.92	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	117.37	109.81	95.29	6.97	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	135.36	116.62	205.12	8.33	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	178.05	125.74	252.39	15.60	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	67.55	294.87	262.00	9.13	1.83
Wilms' tumor cell line:G-401	10809-111A8	38.00	19.98	14.19	8.88	2.47
Wilms' tumor cell line:HFWT	10597-108E3	14.96	29.92	33.44	6.16	4.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	9.50	22.62	14.52	7.26	1.12
achilles tendon, donor2	10292-104G4	14.47	10.33	24.80	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	56.35	19.89	16.57	10.45	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	80.10	19.97	13.70	13.23	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	110.04	28.61	22.32	16.62	3.32
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	66.94	21.77	14.69	19.86	2.99
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	81.51	31.48	23.05	10.12	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	62.39	20.09	15.44	8.04	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	65.33	15.79	22.87	13.07	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	48.03	20.71	20.27	7.93	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	60.03	22.05	17.15	10.62	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	48.15	30.29	17.47	5.82	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	31.65	12.70	12.70	7.36	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	27.30	15.60	19.50	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	73.90	18.59	13.01	10.22	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	42.72	25.89	27.70	11.65	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.17	14.90	19.58	10.23	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.42	51.12	28.35	13.01	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	39.89	15.63	17.27	3.70	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	29.47	62.31	43.89	16.58	3.07
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	63.15	34.14	29.44	10.67	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	67.03	32.45	23.05	10.01	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	79.43	29.13	25.03	13.72	2.89
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	41.43	21.16	11.14	4.68	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	42.69	71.38	59.04	17.34	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	118.93	111.49	72.47	50.17	9.29
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	25.24	12.43	5.65	6.78	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	96.39	75.01	53.21	41.87	6.98
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	69.36	108.72	44.99	58.11	11.25
adenocarcinoma cell line:IM95m	10796-110I4	10.83	20.72	19.78	7.30	1.88
adipose tissue, adult, pool1	10010-101C1	22.80	10.86	10.55	2.17	0.31
adipose, donor1	10184-103D4	103.21	43.39	15.25	11.14	2.35
adipose, donor2	10185-103D5	12.57	31.22	18.25	15.41	0.81
adipose, donor3	10186-103D6	28.32	29.68	16.34	20.42	1.36
adipose, donor4	10187-103D7	29.47	16.47	6.93	11.27	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	29.51	13.10	4.42	13.89	3.79
adrenal gland, adult, pool1	10081-102A9	0.00	25.46	14.55	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	75.37	52.83	51.76	17.74	2.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.59	32.51	31.44	7.50	1.07
amniotic membrane cells, donor1	12235-129G3	9.97	6.96	7.65	2.32	0.00
amniotic membrane cells, donor2	12236-129G4	15.89	8.45	4.40	4.40	0.34
amniotic membrane cells, donor3	12237-129G5	13.26	6.19	5.01	1.18	0.00
amygdala - adult, donor10196	10167-103B5	62.85	90.12	33.20	22.53	9.49
amygdala, adult, donor10252	10151-102I7	60.83	86.78	69.75	26.77	5.07
amygdala, newborn, donor10223	10360-105E9	36.80	35.18	20.33	16.78	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	39.34	8.40	5.98	2.29	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	35.74	32.43	26.70	7.72	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	26.72	48.77	51.11	20.38	2.00
aorta, adult, pool1	10052-101G7	10.59	16.48	12.75	4.31	1.37
appendix, adult	10189-103D9	55.50	42.30	38.81	7.76	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	40.93	14.45	10.32	6.88	1.38
artery, adult	10190-103E1	8.15	12.23	14.95	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	50.99	13.18	10.43	8.26	1.59
b cell line:RPMI1788	10427-106D4	63.64	27.51	16.06	15.46	2.08
basal cell carcinoma cell line:TE 354.T	10702-109G9	15.26	11.10	6.38	1.94	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	55.27	26.79	24.41	8.34	1.49
bile duct carcinoma cell line:TFK-1	10496-107C1	7.87	8.54	7.53	3.18	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	16.22	33.55	21.81	6.71	0.56
bladder, adult, pool1	10011-101C2	25.31	25.42	18.58	5.32	0.43
blood, adult, pool1	10053-101G8	37.65	442.93	467.29	11.07	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	33.40	6.85	7.71	4.28	0.86
bone marrow, adult	10192-103E3	35.09	10.12	11.47	5.40	0.67
brain, adult, donor1	10084-102B3	12.30	53.30	37.93	11.28	3.08
brain, adult, pool1	10012-101C3	55.12	43.32	42.09	21.83	3.56
brain, fetal, pool1	10085-102B4	45.41	82.81	40.07	26.71	10.69
breast carcinoma cell line:MCF7	10482-107A5	26.43	36.34	35.68	6.94	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.71	19.97	23.59	7.99	1.50
breast, adult, donor1	10080-102A8	5.68	46.72	27.15	6.94	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.24	13.59	13.34	6.73	2.79
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.69	20.72	16.39	6.18	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	43.97	3.68	2.30	2.07	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.10	9.20	4.60	3.39	0.73
carcinoid cell line:NCI-H1770	10703-109H1	39.96	20.69	15.05	11.28	0.94
carcinoid cell line:NCI-H727	10735-110B6	26.58	19.91	22.64	8.42	1.31
carcinoid cell line:SK-PN-DW	10719-109I8	28.84	24.08	15.84	11.73	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	108.33	52.44	35.40	15.70	3.19
caudate nucleus - adult, donor10196	10177-103C6	47.20	87.50	58.72	27.63	8.06
caudate nucleus, adult, donor10252	10164-103B2	42.84	53.21	40.49	16.23	3.85
caudate nucleus, adult, donor10258	10379-105H1	31.33	51.20	42.79	20.63	6.11
caudate nucleus, newborn, donor10223	10354-105E3	45.41	36.62	35.16	16.11	2.93
cerebellum - adult, donor10196	10173-103C2	67.01	119.44	87.40	32.05	2.91
cerebellum, adult, donor10252	10166-103B4	51.67	73.45	59.78	18.79	4.27
cerebellum, adult, pool1	10083-102B2	14.83	42.08	31.39	14.49	3.45
cerebellum, newborn, donor10223	10357-105E6	103.79	30.72	21.59	4.98	0.00
cerebral meninges, adult	10188-103D8	31.77	51.18	38.83	24.46	2.52
cerebrospinal fluid, donor2	10294-104G6	9.50	21.20	24.85	8.77	2.19
cervical cancer cell line:D98-AH2	10552-107I3	30.19	10.78	12.08	3.31	0.58
cervical cancer cell line:ME-180	10553-107I4	26.68	14.75	16.07	4.14	0.33
cervix, adult, pool1	10013-101C4	29.71	21.10	18.06	6.19	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	31.63	19.37	18.95	8.08	1.53
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	20.90	11.76	5.23	1.31
choriocarcinoma cell line:BeWo	10423-106C9	56.30	27.96	12.30	19.76	2.36
choriocarcinoma cell line:SCH	10785-110H2	15.40	6.90	4.31	5.17	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	22.77	8.78	3.08	7.59	1.42
chorionic membrane cells, donor1	12238-129G6	9.12	5.13	3.42	1.99	0.00
chorionic membrane cells, donor2	12239-129G7	19.99	8.95	7.16	3.78	0.89
chorionic membrane cells, donor3	12240-129G8	35.17	18.13	17.58	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	53.52	8.08	12.12	9.09	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	41.11	21.13	19.40	8.45	1.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	39.91	34.63	29.57	12.67	2.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	66.51	51.36	43.66	14.64	3.34
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	68.69	60.23	53.70	21.53	3.14
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	86.33	73.91	65.36	20.36	4.68
chronic myelogenous leukemia cell line:K562	10454-106G4	45.05	31.51	23.56	11.48	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	83.92	37.53	32.84	17.20	1.82
clear cell carcinoma cell line:JHOC-5	10638-108I8	47.54	6.40	3.20	3.89	1.14
clear cell carcinoma cell line:TEN	10636-108I6	17.52	10.06	8.68	2.08	0.00
colon carcinoma cell line:CACO-2	10513-107D9	39.17	15.74	9.88	4.76	1.46
colon carcinoma cell line:COLO-320	10420-106C6	55.49	27.75	22.42	25.47	3.80
colon, adult, donor1	10082-102B1	5.95	29.75	17.85	7.14	0.00
colon, adult, pool1	10014-101C5	20.09	18.33	18.10	3.76	1.18
colon, fetal, donor1	10070-101I7	12.98	30.28	25.96	5.56	0.62
common myeloid progenitor CMP, donor1	12130-128D6	68.75	59.59	27.50	32.08	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	50.07	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	87.96	22.10	26.35	7.65	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	79.69	14.19	20.98	9.66	1.81
cord blood derived cell line:COBL-a untreated	10449-106F8	85.03	17.20	21.72	8.04	0.56
corpus callosum, adult, pool1	10042-101F6	49.75	55.61	80.71	15.81	2.32
cruciate ligament, donor2	10295-104G7	14.59	12.16	15.40	3.24	0.81
diaphragm, fetal, donor1	10069-101I6	12.84	23.27	10.43	6.42	1.61
diencephalon, adult	10193-103E4	40.56	44.64	57.12	11.76	2.64
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	42.48	16.99	18.60	7.58	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	52.06	20.52	24.11	7.44	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	27.92	15.17	13.00	4.09	0.48
ductus deferens, adult	10196-103E7	15.95	23.92	22.43	6.48	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	18.72	41.77	46.09	4.32	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	35.31	18.39	14.71	2.94	0.74
dura mater, adult, donor1	10041-101F5	27.67	14.29	17.26	3.80	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	25.32	25.32	18.43	6.22	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	29.81	16.19	12.61	7.74	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	24.05	22.20	23.43	7.40	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	24.52	7.27	8.78	2.72	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.04	21.61	25.01	4.94	1.23
embryonic pancreas cell line:2C6	10603-108E9	36.78	17.08	24.96	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.82	13.07	15.42	10.39	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.61	8.88	6.89	4.89	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	22.19	10.13	8.36	2.73	0.96
epidermoid carcinoma cell line:A431	10426-106D3	33.57	27.23	22.45	8.23	2.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	31.13	16.94	16.39	5.28	1.54
epididymis, adult	10197-103E8	16.95	19.88	20.09	6.91	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	36.19	13.84	7.63	8.52	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.11	12.58	7.08	2.75	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	36.30	14.42	13.76	6.42	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	43.21	22.93	18.50	9.94	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	32.49	18.15	13.44	9.63	0.67
esophagus, adult, pool1	10015-101C6	19.11	15.61	15.29	4.35	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	48.72	24.67	13.53	11.65	2.25
eye - muscle inferior rectus, donor1	10272-104E2	12.07	28.97	41.05	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	12.63	27.35	8.42	2.10
eye - muscle medial, donor2	10299-104H2	8.93	29.76	37.21	5.95	1.49
eye - muscle superior, donor2	10297-104G9	16.05	25.22	38.98	1.15	2.29
eye - vitreous humor, donor1	10268-104D7	24.78	21.86	45.18	5.83	0.00
eye, fetal, donor1	10054-101G9	43.47	33.81	37.63	9.15	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	24.23	17.05	10.39	6.41	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.34	19.94	15.91	8.31	2.14
frontal lobe, adult, pool1	10040-101F4	64.18	49.63	51.51	21.77	4.69
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.81	24.62	16.51	8.41	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	42.79	17.19	6.95	8.05	1.74
gall bladder, adult	10198-103E9	12.80	17.62	16.90	4.10	0.00
gamma delta positive T cells, donor1	11937-126A2	161.59	28.99	28.45	9.13	1.07
gamma delta positive T cells, donor2	11938-126A3	141.55	68.72	47.43	4.48	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.64	21.97	24.71	4.86	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	44.29	31.72	36.75	7.93	0.97
gastric cancer cell line:AZ521	10549-107H9	60.83	11.48	8.36	10.33	3.61
gastric cancer cell line:GSS	10560-108A2	32.95	10.07	4.58	6.41	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	37.01	13.48	13.71	5.03	1.37
giant cell carcinoma cell line:LU65	10487-107B1	8.03	8.61	6.20	2.29	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	53.32	23.09	13.44	8.68	1.68
glassy cell carcinoma cell line:HOKUG	10688-109F4	23.94	17.46	13.97	5.24	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	42.33	22.06	16.36	12.03	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	35.25	27.10	19.66	16.01	2.95
glioblastoma cell line:T98G	10485-107A8	45.58	12.03	10.04	4.64	0.44
glioma cell line:GI-1	10413-106B8	38.37	16.40	14.35	3.81	1.46
globus pallidus - adult, donor10196	10175-103C4	53.21	129.75	102.78	36.45	5.83
globus pallidus, adult, donor10252	10161-103A8	79.82	89.09	99.83	19.28	2.20
globus pallidus, adult, donor10258	10367-105F7	53.40	43.81	76.68	8.22	1.37
globus pallidus, newborn, donor10223	10364-105F4	28.24	30.91	31.44	12.26	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	51.39	46.50	31.81	31.81	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	20.80	9.28	7.36	1.60	0.96
hIPS +CCl2, biol_rep1	14383-156B9	65.19	25.25	21.12	19.28	0.92
hIPS +CCl2, biol_rep2	14384-156C1	50.30	19.66	10.97	7.77	1.37
hIPS +CCl2, biol_rep3	14385-156C2	45.73	21.26	14.17	6.44	0.64
hIPS, biol_rep1	14380-156B6	47.43	10.06	8.62	1.44	0.00
hIPS, biol_rep2	14381-156B7	29.49	17.15	15.77	12.35	1.37
hIPS, biol_rep3	14382-156B8	22.07	40.83	52.97	9.93	3.31
hairy cell leukemia cell line:Mo	10712-109I1	65.23	44.54	42.24	17.24	2.87
heart - mitral valve, adult	10205-103F7	19.73	14.05	11.96	2.99	0.90
heart - pulmonic valve, adult	10206-103F8	16.47	14.38	14.12	5.23	0.78
heart - tricuspid valve, adult	10207-103F9	21.65	15.82	17.49	3.33	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	8.57	7.35	6.53	2.65	0.61
heart, adult, diseased, donor1	10051-101G6	2.13	7.24	4.68	3.41	0.00
heart, adult, pool1	10016-101C7	6.21	10.12	6.44	4.37	0.92
heart, fetal, pool1	10046-101G1	25.26	10.06	12.83	5.75	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	17.89	16.04	15.43	3.70	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	38.05	35.68	17.84	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.10	16.68	13.81	6.52	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	24.64	15.90	10.92	7.65	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	28.09	13.84	12.13	6.77	0.51
hepatoma cell line:Li-7	10484-107A7	21.35	14.79	18.13	5.67	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	51.66	34.17	24.62	11.56	1.81
hippocampus - adult, donor10196	10169-103B7	58.67	88.01	77.60	54.89	11.36
hippocampus, adult, donor10252	10153-102I9	67.15	99.19	83.89	26.94	4.69
hippocampus, adult, donor10258	10374-105G5	37.35	34.86	30.37	13.44	3.49
hippocampus, newborn, donor10223	10363-105F3	32.43	59.57	30.67	27.14	4.23
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	98.88	14.04	16.48	6.10	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	37.90	21.99	14.33	12.57	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	49.26	21.07	8.89	10.41	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.88	33.27	15.22	24.25	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	38.99	37.18	17.56	30.47	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	41.76	27.33	11.39	14.43	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.12	30.07	17.52	14.89	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.47	34.25	22.40	21.33	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	41.71	27.11	17.93	17.93	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	46.65	16.81	14.44	11.37	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	37.45	28.45	20.25	17.04	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.03	15.49	15.49	17.51	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	33.80	18.15	13.14	8.92	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	39.30	14.74	13.76	11.30	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	70.69	14.84	11.35	3.49	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	34.17	42.19	25.77	25.58	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	34.01	40.12	23.98	24.42	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	42.98	27.49	19.99	14.49	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	40.88	27.51	17.33	12.81	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	42.29	23.65	20.92	14.10	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	35.08	23.49	17.85	8.77	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	32.01	22.21	17.80	8.33	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	27.00	19.16	15.10	10.16	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.01	27.20	19.73	7.47	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	43.42	21.43	12.01	9.79	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	37.09	23.68	17.12	9.13	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	75.95	21.23	14.29	6.12	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.60	24.29	17.25	9.86	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	25.66	27.56	14.89	14.57	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.66	23.00	10.59	11.50	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	31.03	22.24	13.96	11.38	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.89	25.24	11.95	13.28	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	31.30	14.37	11.03	7.70	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	33.23	19.94	10.48	5.37	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	39.38	14.39	21.20	7.57	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	31.59	15.46	11.43	5.38	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	40.81	17.63	15.70	10.38	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	54.37	24.51	12.03	12.48	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	46.83	25.37	17.56	14.15	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	31.78	26.89	16.20	18.34	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	344.84	65.06	29.28	22.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	59.24	21.84	15.22	8.27	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	31.20	22.44	22.99	18.61	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	35.10	18.09	13.03	15.56	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	30.60	22.78	12.81	13.88	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	38.19	19.09	16.71	11.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	61.89	23.29	20.58	13.00	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.06	21.01	14.01	8.08	1.35
immature langerhans cells, donor1	11904-125F5	20.58	6.78	10.17	1.70	0.48
immature langerhans cells, donor2	11905-125F6	3.96	3.96	4.75	0.00	0.00
insula, adult, pool1	10039-101F3	35.20	43.25	37.10	23.28	3.69
keratoacanthoma cell line:HKA-1	10791-110H8	7.15	7.15	10.08	2.60	0.00
kidney, adult, pool1	10017-101C8	21.03	7.61	6.61	2.90	0.40
kidney, fetal, pool1	10045-101F9	10.04	11.53	8.70	5.38	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	49.42	10.51	9.52	6.53	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.23	4.84	4.15	3.18	1.11
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.18	18.90	20.00	4.95	0.55
left atrium, adult, donor1	10079-102A7	10.35	22.34	18.52	3.27	0.54
left ventricle, adult, donor1	10078-102A6	5.56	15.68	9.61	3.54	1.01
leiomyoblastoma cell line:G-402	10721-110A1	13.13	30.64	24.08	10.67	3.28
leiomyoma cell line:10964C	10569-108B2	7.18	5.03	2.87	2.51	0.00
leiomyoma cell line:15242A	10570-108B3	9.24	4.35	1.09	1.09	1.09
leiomyoma cell line:15425	10571-108B4	12.87	8.26	5.10	1.21	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	21.96	16.73	8.36	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	48.29	21.25	21.01	6.73	1.53
liposarcoma cell line:KMLS-1	10782-110G8	22.96	11.87	10.78	3.12	0.62
liposarcoma cell line:SW 872	10726-110A6	55.07	35.33	27.05	15.35	3.90
liver, adult, pool1	10018-101C9	6.64	5.51	5.19	1.13	0.65
liver, fetal, pool1	10086-102B5	0.94	11.29	7.53	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	46.96	145.97	92.60	55.56	9.33
locus coeruleus, adult, donor10252	10165-103B3	54.07	59.79	52.23	19.75	3.51
locus coeruleus, adult, donor10258	10375-105G6	31.32	67.71	51.63	17.49	3.95
locus coeruleus, newborn, donor10223	10362-105F2	55.52	22.71	24.40	10.09	2.10
lung adenocarcinoma cell line:A549	10499-107C4	18.82	6.92	5.95	5.95	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	17.24	8.27	27.58	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	24.65	18.72	14.24	9.36	1.85
lung, adult, pool1	10019-101D1	31.42	13.23	9.80	4.37	0.47
lung, fetal, donor1	10068-101I5	70.21	15.41	27.40	8.28	1.43
lung, right lower lobe, adult, donor1	10075-102A3	20.16	38.95	29.78	8.71	2.29
lymph node, adult, donor1	10077-102A5	43.55	34.08	40.71	8.05	1.42
lymphangiectasia cell line:DS-1	10727-110A7	56.33	54.14	37.26	12.93	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	56.90	16.15	22.64	8.15	1.81
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	48.42	28.88	22.94	7.65	2.55
mature adipocyte, donor1	12231-129F8	6.22	11.10	11.99	3.55	0.89
mature adipocyte, donor2	12232-129F9	8.30	15.56	12.45	2.70	0.62
mature adipocyte, donor3	12233-129G1	5.93	15.17	11.14	4.98	1.90
mature adipocyte, donor4	12234-129G2	20.53	17.11	15.27	3.95	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	55.51	35.50	28.35	26.21	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	42.87	73.32	41.74	36.10	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	57.56	90.48	76.51	27.95	4.97
medial frontal gyrus, adult, donor10258	10368-105F8	25.41	57.82	45.11	27.00	4.13
medial frontal gyrus, newborn, donor10223	10352-105E1	184.67	40.52	28.15	13.22	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	73.91	74.42	46.91	32.06	5.91
medial temporal gyrus, adult, donor10252	10156-103A3	64.30	98.05	89.56	22.50	6.37
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	30.82	38.53	7.71	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	645.91	215.30	301.43	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	67.12	44.51	26.56	22.97	6.10
medulla oblongata - adult, donor10196	10174-103C3	41.53	81.77	46.08	20.12	3.24
medulla oblongata, adult, donor10252	10155-103A2	51.70	61.30	48.30	18.58	3.87
medulla oblongata, adult, pool1	10038-101F2	29.06	40.65	40.65	19.43	3.43
medulla oblongata, newborn, donor10223	10361-105F1	37.50	33.68	29.86	12.50	2.78
medulloblastoma cell line:D283 Med	10838-111E1	61.11	21.70	22.58	17.93	1.11
medulloblastoma cell line:ONS-76	10759-110E3	35.46	27.14	20.54	11.25	2.57
melanoma cell line:COLO 679	10514-107E1	27.46	11.50	12.22	4.31	1.15
melanoma cell line:G-361	10465-106H6	19.00	8.14	7.33	3.80	0.27
meningioma cell line:HKBMM	10691-109F7	20.98	6.33	6.87	2.35	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	103.10	62.56	51.99	36.13	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	41.73	15.55	8.30	8.04	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.94	5.52	4.76	1.99	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	20.54	6.00	8.18	0.73	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.53	2.07	7.04	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.59	4.78	4.92	1.26	1.55
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.71	6.35	2.50	2.31	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.19	6.25	2.08	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.04	7.55	8.58	3.09	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.01	6.21	5.52	1.84	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	18.30	5.17	3.45	1.33	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	21.74	3.11	4.86	1.76	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	24.33	7.26	5.69	2.13	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	16.14	10.21	4.94	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.72	6.09	6.37	3.46	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.85	6.98	6.98	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.56	4.49	4.90	2.04	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.94	8.27	3.95	2.52	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.31	4.45	3.83	2.48	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.89	7.75	4.79	1.37	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	42.79	7.55	5.03	2.94	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.20	6.13	2.99	1.20	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.82	5.95	3.94	2.36	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.99	12.15	8.47	3.68	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.31	5.44	4.58	1.72	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	22.31	10.10	6.74	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	5.02	3.20	3.65	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.51	4.60	3.07	1.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.13	7.07	7.07	2.09	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	9.86	5.24	7.09	1.85	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	14.36	4.47	3.29	1.41	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.54	5.42	1.69	1.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.47	8.25	3.14	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.80	4.17	2.32	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.04	7.79	4.90	2.02	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.82	7.14	4.24	1.12	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.02	7.21	5.53	1.20	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	15.40	9.53	5.13	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.73	5.03	4.36	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.46	3.68	6.96	2.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	11.60	6.01	5.15	3.01	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.44	4.22	4.22	1.30	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	4.36	8.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6.40	3.20	3.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	7.36	0.82	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.77	6.22	1.94	2.72	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	4.20	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	6.95	0.99	1.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	8.30	3.56	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	7.31	3.66	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	5.70	2.53	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.66	6.55	2.76	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	2.15	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	6.89	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	7.33	2.85	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	4.77	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	9.43	5.31	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.86	4.99	4.99	1.25	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1.34	4.01	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	7.10	3.55	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	2.57	12.84	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	12.39	8.95	4.82	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.42	8.41	2.97	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	6.73	2.24	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.09	9.54	6.36	3.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.46	11.28	6.45	5.64	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	2.18	10.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	15.20	5.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.10	10.32	11.53	2.43	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	9.04	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	9.06	5.77	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.94	7.34	3.97	1.59	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.11	7.46	4.87	1.62	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	3.06	9.17	6.11	3.06	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	21.66	14.70	12.38	4.64	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	39.69	27.40	17.48	14.17	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	28.26	18.77	11.58	7.88	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	17.09	12.82	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	31.13	20.86	17.78	3.08	1.03
mesothelioma cell line:Mero-25	10850-111F4	35.18	15.21	14.98	4.31	0.00
mesothelioma cell line:Mero-41	10851-111F5	19.07	13.69	11.98	3.42	0.49
mesothelioma cell line:Mero-48a	10852-111F6	15.50	3.76	5.98	3.32	0.44
mesothelioma cell line:Mero-82	10853-111F7	29.96	21.02	23.13	5.52	1.58
mesothelioma cell line:Mero-83	10854-111F8	26.55	16.00	13.62	5.28	1.53
mesothelioma cell line:Mero-84	10855-111F9	12.39	6.32	3.54	4.04	0.25
mesothelioma cell line:Mero-95	10856-111G1	17.60	11.18	5.59	1.86	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	28.16	11.60	13.09	5.47	0.66
mesothelioma cell line:NCI-H226	10846-111E9	18.10	8.87	7.96	2.53	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	24.60	13.67	7.17	5.64	0.85
mesothelioma cell line:NCI-H28	10845-111E8	26.21	12.72	9.16	4.83	0.76
mesothelioma cell line:No36	10857-111G2	16.64	15.98	10.44	2.61	0.65
mesothelioma cell line:ONE58	10858-111G3	14.90	5.69	13.28	3.25	0.54
migratory langerhans cells, donor1	11901-125F2	96.92	24.76	34.74	4.99	0.96
migratory langerhans cells, donor2	11902-125F3	37.00	17.58	16.24	3.30	0.85
migratory langerhans cells, donor3	11903-125F4	77.54	38.41	36.97	6.10	1.44
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.61	18.28	13.71	3.59	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	11.44	8.69	5.30	4.66	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	25.80	46.99	42.62	9.68	1.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	65.65	36.73	50.24	12.94	2.09
myelodysplastic syndrome cell line:SKM-1	10772-110F7	69.11	30.86	27.53	8.50	1.66
myeloma cell line:PCM6	10474-106I6	62.07	13.84	15.42	5.73	1.78
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.86	21.81	14.20	4.57	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	8.24	13.73	23.93	2.35	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.59	5.68	6.35	2.79	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.50	7.06	5.81	1.18	0.37
nasal epithelial cells, donor2	12227-129F4	13.80	4.97	11.59	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	138.04	33.59	49.00	23.70	1.84
neuroblastoma cell line:NB-1	10539-107G8	107.57	33.49	21.14	19.64	4.86
neuroblastoma cell line:NBsusSR	10607-108F4	35.01	17.50	20.25	11.39	2.74
neuroblastoma cell line:NH-12	10555-107I6	81.99	35.22	36.52	12.30	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	37.01	23.72	19.45	14.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	20.11	18.37	13.62	9.98	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	13.89	14.89	8.65	7.45	2.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	22.89	127.15	45.78	47.68	9.54
neurofibroma cell line:Hs 53.T	10729-110A9	19.70	15.44	14.64	1.86	1.06
neutrophil PMN, donor1	12133-128D9	29.75	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	279.05	42.96	19.45	35.85	2.88
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	66.44	24.02	15.21	11.21	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	19.56	6.73	4.49	1.28	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	13.40	5.26	4.99	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	39.56	49.87	47.99	21.19	4.78
occipital cortex - adult, donor10196	10172-103C1	67.99	135.99	90.66	26.78	16.48
occipital cortex, adult, donor10252	10163-103B1	66.29	95.54	90.44	26.30	5.64
occipital cortex, newborn, donor10223	10355-105E4	60.05	49.86	28.75	31.30	2.91
occipital lobe, adult, donor1	10076-102A4	35.16	90.00	78.72	34.64	6.56
occipital lobe, fetal, donor1	10073-102A1	143.32	137.74	97.83	83.25	15.88
occipital pole, adult, pool1	10036-101E9	10.49	25.70	24.91	15.69	2.52
olfactory region, adult	10195-103E6	47.00	59.04	54.07	23.31	5.16
optic nerve, donor1	10277-104E7	66.03	204.11	282.15	30.02	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.25	11.73	17.09	3.87	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	21.98	20.88	16.90	7.97	2.61
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	27.09	16.76	13.72	4.74	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	25.87	19.17	21.83	4.16	1.39
osteoclastoma cell line:Hs 706.T	10704-109H2	9.11	12.93	6.47	3.82	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	91.56	42.05	26.16	28.96	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	23.54	16.96	15.27	5.94	1.27
ovary, adult, pool1	10020-101D2	20.88	20.79	17.91	5.77	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.97	13.57	8.43	2.93	1.28
pancreas, adult, donor1	10049-101G4	8.47	19.75	11.29	2.82	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	27.95	20.97	13.98	13.98	3.35
papillary adenocarcinoma cell line:8505C	10437-106E5	46.17	12.95	9.71	7.50	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.80	17.72	13.58	5.63	0.83
paracentral gyrus, adult, pool1	10035-101E8	30.39	38.16	36.15	23.70	3.39
parietal cortex, adult, donor10258	10373-105G4	29.36	32.30	33.76	14.68	1.47
parietal lobe - adult, donor10196	10171-103B9	37.62	87.46	47.02	33.86	8.46
parietal lobe, adult, donor10252	10157-103A4	57.01	74.11	70.69	24.23	5.70
parietal lobe, adult, pool1	10034-101E7	27.67	44.41	41.77	20.88	2.73
parietal lobe, fetal, donor1	10072-101I9	220.15	168.75	121.23	75.65	11.64
parietal lobe, newborn, donor10223	10356-105E5	74.77	37.76	32.15	20.94	3.74
parotid gland, adult	10199-103F1	5.55	12.33	6.17	5.55	0.62
penis, adult	10200-103F2	17.19	17.19	16.11	2.15	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	23.99	8.18	6.88	3.53	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	24.19	26.08	14.86	7.43	1.46
pineal gland - adult, donor10196	10179-103C8	30.32	117.39	78.05	44.51	7.10
pineal gland, adult, donor10252	10160-103A7	74.03	99.49	66.33	43.23	6.51
pineal gland, adult, donor10258	10377-105G8	35.12	66.47	35.12	35.12	3.14
pituitary gland - adult, donor10196	10180-103C9	67.79	43.51	23.27	17.20	2.02
pituitary gland, adult, donor10252	10162-103A9	82.35	63.06	52.64	18.24	4.69
pituitary gland, adult, donor10258	10378-105G9	32.35	43.41	30.64	9.36	4.26
placenta, adult, pool1	10021-101D3	55.04	63.96	56.76	12.26	2.69
plasma cell leukemia cell line:ARH-77	10840-111E3	45.42	22.91	13.51	9.80	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	21.01	13.85	15.88	4.36	1.09
pons, adult, pool1	10033-101E6	59.56	51.90	46.73	21.69	5.34
postcentral gyrus, adult, pool1	10032-101E5	17.44	31.56	29.47	15.52	2.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	29.28	8.37	8.37	12.55	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	11.02	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	31.03	9.47	4.22	8.59	1.75
prostate cancer cell line:PC-3	10439-106E7	36.12	15.97	12.34	15.43	1.09
prostate, adult, pool1	10022-101D4	21.22	16.51	15.87	6.17	0.27
putamen, adult, donor10196	10176-103C5	51.93	67.51	38.95	25.73	4.25
putamen, adult, donor10252	10152-102I8	11.76	31.37	27.45	11.76	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	37.16	22.95	20.76	7.65	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	23.19	46.87	28.75	14.50	2.66
putamen, newborn, donor10223	10365-105F5	90.71	28.49	23.24	2.25	1.50
rectal cancer cell line:TT1TKB	10469-106I1	15.71	25.02	20.37	11.64	0.87
rectum, fetal, donor1	10067-101I4	36.17	54.25	47.29	12.52	9.74
renal cell carcinoma cell line:OS-RC-2	10411-106B6	41.13	11.02	11.02	6.57	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	43.91	5.38	2.90	4.97	0.00
retina, adult, pool1	10030-101E3	18.19	20.28	24.55	7.55	0.80
retinoblastoma cell line:Y79	10475-106I7	47.80	26.24	18.97	13.77	2.60
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.68	19.79	15.74	9.10	2.83
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	172.94	97.30	71.42	62.71	9.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	17.43	15.91	3.79	0.76
salivary acinar cells, donor1	11771-123I7	26.06	11.65	10.20	3.40	0.81
salivary acinar cells, donor2	11772-123I8	15.42	8.95	7.57	2.34	0.14
salivary acinar cells, donor3	11773-123I9	14.57	31.78	23.83	9.27	1.99
salivary gland, adult, pool1	10093-102C3	10.30	5.72	9.15	2.86	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	46.37	20.57	18.13	5.56	1.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	38.56	20.57	19.87	6.35	2.12
seminal vesicle, adult	10201-103F3	20.63	24.34	20.10	6.88	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.16	9.72	10.93	2.43	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.80	10.82	8.05	5.28	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	31.11	12.04	7.02	5.02	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	17.33	13.30	15.04	4.16	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	19.34	10.50	14.81	4.53	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	14.58	8.77	11.35	2.97	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	6.38	4.97	12.06	4.26	0.00
skeletal muscle, adult, pool1	10023-101D5	8.40	8.04	6.72	2.16	0.24
skeletal muscle, fetal, donor1	10066-101I3	13.07	29.15	19.10	7.04	2.01
skin, adult, donor1	10074-102A2	13.57	33.93	40.71	0.00	0.00
skin, fetal, donor1	10065-101I2	32.82	22.72	20.83	4.42	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	50.36	32.69	23.01	15.01	3.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	15.76	9.14	7.56	2.84	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	60.33	12.91	3.08	15.03	2.89
small cell lung carcinoma cell line:LK-2	10541-107H1	71.54	33.79	34.78	22.42	2.31
small cell lung carcinoma cell line:NCI-H82	10842-111E5	37.80	19.62	12.22	21.07	1.77
small cell lung carcinoma cell line:WA-hT	10562-108A4	39.23	11.77	11.55	7.19	2.62
small intestine, adult, pool1	10024-101D6	29.38	29.50	27.59	6.33	1.07
small intestine, fetal, donor1	10064-101I1	15.48	29.24	26.04	6.63	2.46
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.65	8.21	14.87	3.08	0.51
smooth muscle, adult, pool1	10048-101G3	14.73	32.31	34.12	7.24	1.29
somatostatinoma cell line:QGP-1	10781-110G7	68.35	44.49	56.55	11.79	1.61
spinal cord - adult, donor10196	10181-103D1	62.17	151.64	89.93	44.73	8.49
spinal cord, adult, donor10252	10159-103A6	79.64	70.57	60.72	21.29	3.94
spinal cord, adult, donor10258	10369-105F9	86.47	31.82	41.51	6.92	0.69
spinal cord, fetal, donor1	10056-101H2	39.03	51.84	40.86	18.90	6.71
spinal cord, newborn, donor10223	10359-105E8	63.83	27.55	31.69	6.43	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.66	18.22	14.79	4.18	1.34
spleen, adult, pool1	10025-101D7	46.26	18.17	16.41	5.51	1.32
spleen, fetal, pool1	10044-101F8	22.33	12.95	13.11	4.37	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	38.30	11.08	10.77	4.45	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.76	10.44	7.41	3.42	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	16.07	8.74	9.78	4.19	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	29.71	20.33	27.37	2.35	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	9.79	8.89	10.47	2.03	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.33	27.96	13.56	6.78	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	26.65	24.54	12.27	7.62	1.69
stomach, fetal, donor1	10062-101H8	28.84	48.06	44.85	11.75	2.14
submaxillary gland, adult	10202-103F4	23.93	13.67	9.68	2.85	1.14
substantia nigra - adult, donor10196	10178-103C7	217.10	108.55	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	72.49	64.80	78.10	7.89	2.28
substantia nigra, adult, donor10258	10371-105G2	53.28	47.07	54.83	21.21	4.14
substantia nigra, newborn, donor10223	10358-105E7	38.16	43.10	39.57	4.95	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	51.36	13.30	8.71	11.23	2.06
temporal lobe, adult, pool1	10031-101E4	14.58	27.47	27.21	17.63	2.12
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	133.91	124.65	76.21	66.24	8.55
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	143.29	62.41	43.07	25.49	5.71
tenocyte, donor1	11763-123H8	13.61	9.43	5.93	1.75	0.70
tenocyte, donor2	11765-123I1	11.06	5.34	4.20	1.14	0.38
tenocyte, donor3	11768-123I4	12.23	4.08	4.82	1.85	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	59.32	24.64	17.51	12.07	3.91
teratocarcinoma cell line:NCR-G1	10798-110I6	41.31	24.66	21.73	10.48	1.23
teratocarcinoma cell line:PA-1	10807-111A6	40.45	30.22	20.30	16.12	2.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	46.59	22.60	17.39	9.39	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	51.05	17.40	12.10	15.51	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	95.97	10.14	9.60	7.09	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	53.42	14.66	11.07	6.51	1.95
testis, adult, pool1	10026-101D8	35.76	32.96	18.15	69.68	6.55
testis, adult, pool2	10096-102C6	17.14	41.05	27.07	94.73	7.67
thalamus - adult, donor10196	10168-103B6	55.20	102.67	82.80	29.81	6.62
thalamus, adult, donor10252	10154-103A1	82.83	69.23	88.46	16.10	3.44
thalamus, adult, donor10258, tech_rep1	10370-105G1	49.27	35.41	52.35	13.86	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	27.67	61.10	43.48	18.45	5.76
thalamus, newborn, donor10223	10366-105F6	67.31	36.25	23.01	6.90	2.88
throat, adult	10209-103G2	19.47	20.22	13.23	3.25	0.75
throat, fetal, donor1	10061-101H7	26.81	25.29	20.11	9.75	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	21.07	16.89	7.55	7.35	1.19
thymus, adult, pool1	10027-101D9	137.69	35.69	28.43	23.26	2.58
thymus, fetal, pool1	10043-101F7	131.54	28.99	27.95	19.22	2.08
thyroid carcinoma cell line:KHM-5M	10776-110G2	35.63	23.80	11.04	4.52	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	34.78	28.22	15.79	10.76	2.65
thyroid, adult, pool1	10028-101E1	20.62	8.68	6.63	4.85	0.47
thyroid, fetal, donor1	10060-101H6	13.18	23.73	21.36	9.23	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	24.64	46.19	6.16	0.00
tongue, adult	10203-103F5	12.56	13.72	12.09	3.26	0.00
tongue, fetal, donor1	10059-101H5	11.03	13.79	13.01	4.73	0.00
tonsil, adult, pool1	10047-101G2	23.84	17.13	16.73	6.91	0.60
trachea, adult, pool1	10029-101E2	28.22	12.68	14.31	4.74	0.49
trachea, fetal, donor1	10058-101H4	17.31	17.31	16.16	9.23	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	15.59	16.65	4.61	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	56.84	27.15	19.25	11.75	1.82
transitional-cell carcinoma cell line:JMSU1	10492-107B6	55.78	32.12	17.24	14.57	4.39
tridermal teratoma cell line:HGRT	10694-109G1	34.25	34.25	20.93	11.42	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	29.88	17.18	15.66	5.59	1.27
umbilical cord, fetal, donor1	10057-101H3	16.69	14.61	10.43	2.09	0.00
uterus, adult, pool1	10100-102D1	21.84	13.14	22.01	5.29	0.68
uterus, fetal, donor1	10055-101H1	24.57	28.16	19.45	6.66	2.56
vagina, adult	10204-103F6	20.03	42.00	30.37	5.82	0.65
vein, adult	10191-103E2	25.87	18.85	21.26	5.92	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	32.04	21.90	13.89	6.41	1.60

Property "Nearest transcripts" (as page type) with input value "ENST00000504883.2:221 ENST00000675085.1:221 ENST00000514082.6:221 ENST00000407818.8:221 ENST00000674632.1:221 ENST00000674916.1:221 ENST00000676413.1:221 ENST00000676122.1:221 ENST00000674751.1:221 ENST00000509663.2:221 NM_001243953.2:221 NM_004520.5:221 NM_001098511.3:221 NM_001243952.2:221 ENST00000381103.7:266 BC047544:266 AK297347:431 ENST00000676271.1:467 AK307880:467 EF560716:467 EF560728:473 EU832810:486 GQ129246:486 AK315866:493" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.